THERAPEUTIC BENEFIT OF ADJUVANT GEMCITABINE-CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH INVASIVE TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT

Authors :: K.S. Cho
S.H. Doo
I.R. Cho
H.S. Kim
S.H. Chun
K.H. Song
B.H. Chung
D.H. Seong
Y.S. Kim
D.H. Lee
S.J. Kim
C.I. Kim
Y.S. Song
J.H. Yun
J.S. Cho
S.J. Hong
W.J. Yang
S.I. Kim
Y.D. Choi
D.J. Kim
Source :: European Urology Supplements. 7:221
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
medicine.medical_treatment
Gemcitabine/cisplatin
Combination chemotherapy
medicine.disease
Transitional cell carcinoma
Internal medicine
medicine
business
Adjuvant
Upper urinary tract

Tools